- Home
- NMIH vs XENE Comparison
NMIH vs XENE Comparison
Compare NMIH & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMIH | XENE |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.2B |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NMIH | XENE |
|---|---|---|
| Price | $36.87 | $54.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $43.00 | ★ $67.17 |
| AVG Volume (30 Days) | 339.8K | ★ 1.7M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.06 | N/A |
| EPS | ★ 4.92 | N/A |
| Revenue | ★ $706,440,000.00 | $311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.34 | $2,436.26 |
| P/E Ratio | $7.62 | ★ N/A |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $32.71 | $26.74 |
| 52 Week High | $43.20 | $62.91 |
Technical Indicators
Market Signals| Indicator | NMIH | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 58.97 |
| Support Level | $36.67 | $39.93 |
| Resistance Level | $37.66 | $62.91 |
| Average True Range (ATR) | 0.71 | 2.05 |
| MACD | -0.01 | -0.33 |
| Stochastic Oscillator | 22.25 | 20.46 |
Price Performance
Historical ComparisonAbout NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.